Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) EPS (Weighted Average and Diluted): 2021-2024

Historic EPS (Weighted Average and Diluted) for Biodesix (BDSX) over the last 4 years, with Dec 2024 value amounting to -$0.33.

  • Biodesix's EPS (Weighted Average and Diluted) rose 17.14% to -$1.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.96, marking a year-over-year increase of 331.58%. This contributed to the annual value of -$0.33 for FY2024, which is 48.44% up from last year.
  • As of FY2024, Biodesix's EPS (Weighted Average and Diluted) stood at -$0.33, which was up 48.44% from -$0.64 recorded in FY2023.
  • Biodesix's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.33 during FY2024, with a 5-year trough of -$1.58 in FY2021.
  • Over the past 3 years, Biodesix's median EPS (Weighted Average and Diluted) value was -$0.64 (recorded in 2023), while the average stood at -$0.84.
  • Data for Biodesix's EPS (Weighted Average and Diluted) shows a peak YoY soared of 58.71% (in 2023) over the last 5 years.
  • Yearly analysis of 4 years shows Biodesix's EPS (Weighted Average and Diluted) stood at -$1.58 in 2021, then grew by 1.90% to -$1.55 in 2022, then spiked by 58.71% to -$0.64 in 2023, then soared by 48.44% to -$0.33 in 2024.